Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
 Best Of PandemicsBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd
Search
Shrewd'm.com Merry shrewd investors
Search
Best Of PandemicsBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd

The week's question
In December 2024, in the thread "Re: BRK: Why Not XOM?", BreckHutHigh asked the members: "What about the long road trips with kids?" This week it is put to everyone again. The button below opens the small thread re-asking it - read what others have said so far, then give your own answer as an ordinary reply.
Answer this questionContinue to Shrewd'mThis note won't appear again
Outskirts of Shrewd'm / Pandemics
Unthreaded | Threaded | Whole Thread (9) |
Author: g0177325 ⎊✺  😊 😞
Number: of 78 
Subject: Updated COVID Shots are nigh!
Date: 08/23/24 9:06 AM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 1
From cnbc.com - Covid vaccines FDA approves pfizer moderna updated shots

FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

The Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, putting the new shots on track to reach most Americans in the coming days amid a summer surge of the virus.

The jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began circulating widely in the U.S. earlier this year. KP.2 was the dominant Covid strain in May, but now only accounts for roughly 3% of all U.S. cases as of Saturday, according to the latest Centers for Disease Control and Prevention data.

Still, Pfizer and Moderna have said their KP.2 vaccines can produce stronger immune responses against other circulating subvariants of JN.1, such as KP.3 and LB.1, than last year’s round of shots targeting the omicron strain XBB.1.5 can.

“Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.
Post New | Post Reply | Report Post | Recommend It!
Print the post
Members reply directly to g0177325 here — and replies get answered. Reading is free; so is joining the conversation. Join Shrewd'm »
This community has written 78 posts about Pandemics. The article-length ones it recommended most:
TYLENOL & AUTISM · 4 recs · 2025
Moved · 4 recs · 2025
The last NYT "Virus Briefing" email until further · 3 recs · 2023
Prep · 2 recs · 2024
Medical Ethics · 1 recs · 2023
Unthreaded | Threaded | Whole Thread (9) |


Announcements
Pandemics FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Ticker or Board Name Author

Best Of Pandemics | Best Of | Favourites & Replies | All Boards | Followed Shrewds | Open Questions | Moving a community